Evaluating wearable sensors for objective measurement of motor features in Parkinson disease and Huntington disease – a pilot study
Objective: Evaluate the feasibility of wearable sensors in measuring motor features of individuals with PD, HD, prodromal HD, and controls in clinic and at home.…Determinant factors of treatment adherence in Parkinson’s disease
Objective: To determine factors predicting treatment adherence in patients with idiopathic Parkinson’s disease. Background: Parkinson’s disease is the second most common cause of neurodegenerative disease…Cognitive and demographic predictors of progression to MCI and dementia in Parkinson’s disease
Objective: To determine the association between demographic and cognitive features and subsequent progression of cognitive symptoms in Parkinson’s disease (PD). Background: Most patients diagnosed with…Rotenone induces astrocyte-mediated non-cell autonomous dopaminergic neurotoxicity
Objective: In this study, we examined involvement of astrocytes in rotenone-induced dopaminergic neurotoxicity using primary cultured cells. Background: Several studies reported that pesticide exposure, such…Intention Awareness in Parkinson’s Disease
Objective: To investigate the role of dopamine in intention awareness of voluntary actions in patients with Parkinson’s Disease (PD). Background: Underactivation of the SMA due…SNCA multiplication consortium: Clinicogenetic analysis of SNCA multiplication probands and families.
Objective: Clinicogenetic analysis of 57 affected probands with SNCA multiplication, 3 unaffected carriers, and their 60 families. To use informative pedigrees to identify penetrance modifiers…Parkinsonian Features in a Cohort of Gaucher’s Disease (GD) Patients and Relatives.
Objective: to investigate the prevalence and clinical features of parkinsonism in a cohort of 21 GD patients and their relatives. Background: GD is a lysosomal…Short term effects of bilateral STN DBS on psychiatric profile in Parkinson’s disease
Objective: We intend to look into the effects of bilateral STN DBS on Psychiatric profile of Parkinson’s patients. Background: Parkinson’s disease is a well-known degenerative…Assessing Bone Health in Parkinson’s – When and how?
Objective: To assess the impact of, and practicality of, assessing bone health routinely in people newly diagnosed with Parkinson’s disease in a South Wales University…PROMESA: Progression Rate of MSA under EGCG Supplementation as anti-Aggregation-Approach – evaluation of serious adverse events
Objective: In the PROMESA trial (ClinicalTrials Identifier: NCT02008721) Epigallocatechingallate (EGCG) a catechine that prevents pathological protein aggregation in vitro and can be purified from green…
- « Previous Page
- 1
- …
- 294
- 295
- 296
- 297
- 298
- …
- 388
- Next Page »